After many years in this industry, one truth has become clear to us: all clinical trials and investigations must be a ‘fair game’. Fairness to the patients who volunteer their time and trust. Fairness to the caregivers who support them. And fairness to the sponsors who invest in advancing medical innovation. Finally, fairness to the regulators who are responsible for ensuring the safety and efficacy of new therapies and diagnostics tools. Clinical research inevitably places a burden on all of these stakeholders. On the one hand, promising therapies should not be held back by inefficiencies or avoidable delays, on the other, ineffective and/or unsafe ones should be put to end as early as possible.
Rigorous & Strategic statistical planning alongside rigorous clinical and operational planning can often minimize that burden while maximizing the value and integrity of the data.
As consulting statisticians, our work is not just about data analysis and inference; it is about enabling efficient, robust and risk-mitigated strategies and study designs for clinical trials.
Our role as consultants provides us a unique vantage point across the industry. We consistently observe that many late-stage failures can be traced back to gaps in learning and/or planning in the early stages. By addressing these gaps proactively, we help our clients build efficient study pipelines, reduce avoidable risks, thus increasing the likelihood of meaningful success.
The principles that guide our work and define our commitment to excellence in statistical consulting and data science.
We commit to accuracy, transparency, and rigor in every analysis, ensuring decisions are grounded in truth—not convenience. We embrace new statistical and computational methodologies to solve and troubleshoot bottlenecks commonly encountered in clinical investigations across a range of therapeutic areas and diagnostics devices.
People are at the heart of clinical research. Our consulting philosophy and approach is establishing efficacy or lack of it using efficient and robust statistical strategies.
We uphold fairness to patients, caregivers, investigators, sponsors and regulators—balancing scientific and business needs with humane and ethical responsibility.
We believe well-planned studies reduce risk, accelerate timelines, and prevent costly failures downstream.
We work alongside clinical teams, investigators, and sponsors as strategic partners—not just consultants—co-creating solutions to complex challenges and bottlenecks.
We embrace new statistical methodologies including data-driven approaches while respecting regulatory guidance, interpretability, generalizability and reproducibility.
We translate complexity into actionable insights—ensuring stakeholders understand proposed strategies for data collection and analysis and thus can contribute to further improve and streamline such strategies. We thrive in collaborative engagements.
We stay at the forefront of evolving statistical and computing methodologies, regulatory guidance, and technology—because excellence requires continuous learning.
We are a curated team of seasoned international experts dedicated to making a profound impact on healthcare and improving patient outcomes worldwide.
Founder and Chief Statistical Consultant
Chief Data Scientist
Chief of Marketing Strategy
and Operations